Dr. Emad Yuzbashian completed his Ph.D. in Human Nutrition at the University of Alberta, where his research focused on the metabolic effects of dietary interventions in the context of obesity and related disorders. Additionally, he has a strong background in nutritional epidemiology, analyzing large cohort studies on dietary patterns and chronic disease. He is proficient in multi-omic integration, combining microbiome, lipidomics, and metabolomics data to understand host–diet–microbe interactions. Dr. Yuzbashian’s research excellence has been recognized through multiple awards, including the Alberta Diabetes Institute and International Helmholtz Research School for Diabetes (ADI/HRD) Award. His current postdoctoral research at UBC Okanagan explores the synergy between genetically engineered probiotics (BioPersist™) and host microbial communities shaped by distinct dietary patterns. Using advanced gnotobiotic mouse models, he investigates how these interactions influence the severity of colitis and its metabolic and neurobehavioral comorbidities. His work contributes to the development of personalized, microbiome-informed interventions for chronic inflammatory diseases.